Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

No impact of NOD2/CARD15 on outcome after SCT: a reply

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Sairafi D, Uzunel M, Remberger M, Ringden O, Mattsson J . No impact of NOD2/CARD15 on outcome after SCT. Bone Marrow Transplant 2008; 41: 961–964.

    Article  CAS  PubMed  Google Scholar 

  2. Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S et al. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J Clin Oncol 2007; 25: 4262–4269.

    Article  CAS  PubMed  Google Scholar 

  3. Holler E, Rogler G, Brenmoehl J, Hahn J, Herfarth H, Greinix H et al. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 2006; 107: 4189–4193.

    Article  CAS  PubMed  Google Scholar 

  4. Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn J et al. Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004; 104: 889–894.

    Article  CAS  Google Scholar 

  5. Granell M, Urbano-Ispizua A, Arostegui JI, Fernandez-Aviles F, Martinez C, Rovira M et al. Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation. Haematologica 2006; 91: 1372–1376.

    CAS  PubMed  Google Scholar 

  6. Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006; 81: 247–254.

    Article  CAS  Google Scholar 

  7. Holler E, Hahn J, Andreesen R, Rogler G, Brenmoehl J, Greinix H et al. NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters. J Clin Oncol 2008; 26: 338–339.

    Article  CAS  PubMed  Google Scholar 

  8. Mayor NP, Shaw BE, Hughes DA, Maldonado-Torres H, Madrigal JA, Keshav S et al. In Reply. J Clin Oncol 2008; 26: 339.

    Article  CAS  Google Scholar 

  9. Hugot JP, Zaccaria I, Cavanaugh J, Yang H, Vermeire S, Lappalainen M et al. Prevalence of CARD15/NOD2 mutations in Caucasian healthy people. Am J Gastroenterol 2007; 102: 1259–1267.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S G E Marsh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mayor, N., Shaw, B., Madrigal, J. et al. No impact of NOD2/CARD15 on outcome after SCT: a reply. Bone Marrow Transplant 42, 837–838 (2008). https://doi.org/10.1038/bmt.2008.251

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.251

This article is cited by

Search

Quick links